Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 19 studies | 49% ± 12% | |
| lung | 18 studies | 55% ± 18% | |
| intestine | 13 studies | 42% ± 21% | |
| kidney | 9 studies | 48% ± 12% | |
| liver | 6 studies | 45% ± 23% | |
| pancreas | 5 studies | 55% ± 20% | |
| bone marrow | 5 studies | 40% ± 21% | |
| uterus | 5 studies | 54% ± 20% | |
| lymph node | 5 studies | 50% ± 20% | |
| placenta | 4 studies | 69% ± 20% | |
| eye | 4 studies | 30% ± 7% | |
| brain | 4 studies | 37% ± 12% | |
| prostate | 4 studies | 49% ± 9% | |
| breast | 4 studies | 54% ± 1% | |
| adrenal gland | 3 studies | 38% ± 4% | |
| esophagus | 3 studies | 52% ± 24% | |
| skin | 3 studies | 33% ± 7% | |
| thymus | 3 studies | 58% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3429.31 | 1445 / 1445 | 100% | 23.57 | 183 / 183 |
| ovary | 100% | 2232.66 | 180 / 180 | 100% | 40.52 | 429 / 430 |
| uterus | 100% | 2961.14 | 170 / 170 | 99% | 19.85 | 454 / 459 |
| stomach | 100% | 3242.24 | 359 / 359 | 99% | 36.10 | 282 / 286 |
| lung | 100% | 4972.48 | 578 / 578 | 98% | 14.56 | 1133 / 1155 |
| intestine | 100% | 3649.42 | 966 / 966 | 98% | 34.25 | 516 / 527 |
| bladder | 100% | 3070.24 | 21 / 21 | 98% | 26.94 | 492 / 504 |
| skin | 100% | 3265.54 | 1808 / 1809 | 98% | 16.99 | 461 / 472 |
| thymus | 100% | 3484.02 | 653 / 653 | 97% | 14.19 | 586 / 605 |
| prostate | 100% | 3062.64 | 245 / 245 | 95% | 13.77 | 477 / 502 |
| pancreas | 100% | 2004.16 | 327 / 328 | 95% | 20.49 | 169 / 178 |
| kidney | 100% | 4337.08 | 89 / 89 | 92% | 10.38 | 830 / 901 |
| liver | 100% | 2714.40 | 226 / 226 | 92% | 13.55 | 372 / 406 |
| breast | 100% | 3483.48 | 459 / 459 | 91% | 11.63 | 1020 / 1118 |
| adrenal gland | 100% | 2671.15 | 258 / 258 | 86% | 8.49 | 197 / 230 |
| brain | 81% | 1156.80 | 2139 / 2642 | 76% | 13.11 | 533 / 705 |
| adipose | 100% | 3695.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 17.76 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 21.14 | 29 / 29 |
| muscle | 100% | 4475.06 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4466.39 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.77 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.86 | 1 / 1 |
| peripheral blood | 100% | 7996.78 | 928 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3808.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 4924.69 | 857 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0072513 | Biological process | positive regulation of secondary heart field cardioblast proliferation |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_2000179 | Biological process | positive regulation of neural precursor cell proliferation |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0030165 | Molecular function | PDZ domain binding |
| GO_0031681 | Molecular function | G-protein beta-subunit binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | GNG5 |
| Protein name | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 |
| Synonyms | GNGT5 |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. |
| Accessions | ENST00000370641.3 ENST00000370645.9 ENST00000686161.1 P63218 |